BioSpace News Archive

Business

Adverum Biotechnologies to Host a Conference Call and Webcast to Present New Data from the OPTIC Phase 1 Trial with ADVM-022 Intravitreal Gene Therapy in Wet AMD

Company to host conference call and webcast with key opinion leaders on Monday, May 4, 2020 at 2:15 pm PT

April 27, 2020
·
1 min read
Deals

Marinus Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - April 27, 2020

Marinus Pharmaceuticals, Inc., a pharmaceutical company dedicated to the development of innovative therapeutics to treat rare seizure disorders, announced the grant of inducement awards to two new employees.

April 27, 2020
·
4 min read
Deals

Immunomedics Announces Proposed Public Offering Of Common Stock - April 27, 2020

Immunomedics, Inc., a leading biopharmaceutical company in the area of antibody-drug conjugates, announced it has commenced an underwritten public offering of $350,000,000 of shares of its common stock.

April 27, 2020
·
4 min read
Drug Development

I-Mab and MorphoSys Announce First Patient Dosed in Phase 3 Clinical Trial of TJ202/MOR202 in r/r Multiple Myeloma in Mainland China

I-Mab and MorphoSys AG jointly announced that the first patient has been dosed in a phase 3 clinical study in mainland China to evaluate MorphoSys’ investigational human CD38 antibody TJ202/MOR202 in combination with lenalidomide plus dexamethasone in patients with relapsed or refractory multiple myeloma.

April 27, 2020
·
9 min read
Deals

Aeglea BioTherapeutics Announces Proposed Public Offering - April 27, 2020

Aeglea BioTherapeutics, Inc. announced a proposed underwritten public offering in which it intends to offer and sell $100 million of shares of its common stock and, in lieu of common stock, to offer and sell to certain investors pre-funded warrants to purchase shares of its common stock.

April 27, 2020
·
4 min read
Genetown

CVS Health to Significantly Expand COVID-19 Testing Capabilities

CVS Health will join other pharmacy chains and retailers at the White House to announce the next phase in COVID-19 testing.

April 27, 2020
·
2 min read
Drug Development

Syndax Pharmaceuticals Announces Preclinical Profile and Initial Phase 1 Data Demonstrating Clinical Activity of Menin Inhibitor SNDX-5613 in Adults with Relapsed/Refractory Acute Leukemias

Preliminary Phase 1 results represent first clinical evidence that inhibition of the menin-MLL1 interaction can induce response in patients with MLL-r acute leukemias

April 27, 2020
·
10 min read
BioMidwest

AtriCure to Participate at Upcoming Investor Conferences in May 12, 2020

AtriCure, Inc., a leading innovator in surgical treatments for atrial fibrillation and left atrial appendage management, announced that the company will be participating in two upcoming investor conferences.

April 27, 2020
·
1 min read
Business

Intuitive Appoints Joseph C. Beery to its Board of Directors

Intuitive, a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, announced the election of Joseph C. Beery to its board of directors, effective April 23, 2020..

April 27, 2020
·
2 min read
Business

Universal Health Services, Inc. Reports 2020 First Quarter Financial Results And Uncertainties Related To COVID-19

Consolidated Results of Operations, As Reported and As Adjusted - Three-month periods ended March 31, 2020 and 2019

April 27, 2020
·
30 min read